Roivant Sciences Ltd.ROIVNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
7.62%
↑ 199% above average
Average (11q)
2.55%
Historical baseline
Range
High:18.13%
Low:-8.27%
Volatility
1036.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 7.62% |
| Q2 2025 | 5.29% |
| Q1 2025 | 2.57% |
| Q4 2024 | -0.53% |
| Q3 2024 | 18.13% |
| Q2 2024 | 12.96% |
| Q1 2024 | -1.36% |
| Q4 2023 | -5.79% |
| Q3 2023 | -8.27% |
| Q2 2023 | -5.10% |
| Q1 2023 | 5.04% |
| Q4 2022 | 0.00% |